Global Pharmaceutical Development, Inc., Becomes 'Aptuit'

Name Change Sets Stage for New Phase of Company Growth and Investment

11-Jul-2005

Aptuit, Inc. is the new name of an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators, the founders announced today. The company was formerly called Global Pharmaceutical Development, Inc. The name change coincides with the beginning of a phase of acquisition and investment to build an integrated and highly-differentiated drug development offering.

According to Michael A. Griffith, Aptuit's Chief Executive Officer: "The name Aptuit is derived from 'aptitude' and 'intuition', and reflects the combination of natural abilities required to succeed in the complex drug development process. The name Aptuit also captures the human qualities of intelligence and insight that are required to deliver our vision to engineer a better drug development process to more efficiently achieve milestones for our pharmaceutical and biotech customers. As our firm evolves in the coming months, we will be providing clients with new technologies, infrastructure and services that compress timelines, maintain quality and reduce the overall costs of commercializing new drugs."

Aptuit will provide a comprehensive suite of product development services and competencies to biotechnology and pharmaceutical innovators worldwide. Aptuit's services will include strategic consulting, preclinical testing, formulation, active ingredient development and clinical materials supply and project management, technology transfer and regulatory excellence, all designed to enable clients to advance chemical and biological product candidates more efficiently towards milestones in strict compliance with regulatory requirements.

"We plan to work with our clients to engineer a better drug development process by helping them to identify and integrate new technologies and to build the industry's first seamless IT system that enables end-to-end customer-accessible project management status and test data," Mr. Griffith added.

https://www.bionity.com/en/news/47595/global-pharmaceutical-development-inc-becomes-aptuit.html